Skip to main content

Table 1 Baseline features of 31 participants and characteristics of the tumor and treatment with106Ru brachytherapy

From: Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography

Features  
Mean Age (median, range-Y) 51 (55, 22–74)
Sex (F) 18 (56.8%)
Mean BCVA (median, range-LogMAR) 0.71 (0.52, 0.00–3.00)
Involved eye (OD) 20 (62.5%)
Mean distance to fovea (median, range-mm) 3.53 (3.00, 2.00–12.00)
Mean distance to optic disc (median, range-mm) 3.81 (3.00, 0.00–12.00)
Mean largest tumor diameter (median, range-mm) 14.08 (14.00,8.50–21.00)
Mean thickness (median, range-mm) 6.75 (6.70, 2.84–10)
Mean foveal dose (median, range-Gy) 45.76 (11.00, 0.00–501)
Mean optic disc dose (median, range-Gy) 32.91 (13.50, 0.00–266)
Mean apex dose (median, range-Gy) 84.29 (85, 40–100)